bhvi2
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 31, 2018 (NCT03690414)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04301323 | Phase 1/Phase 2 (Phase 2) | Oct 26, 2019 | Brien Holden Vision Institute, Hai Eye Eye Care |
| NCT03690414 | Phase 1 | Oct 31, 2018 | Brien Holden Vision, Hai Eye Eye Care |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hai Eye Eye Care | Academic/Hospital | 2 | 2 | 2 | 2018 |
| Brien Holden Vision | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Brien Holden Vision Institute | Academic/Hospital | 1 | 0 | 1 | 2019 |
3 organizations
Page 1 / 1